1. Home
  2. DCTH vs TTI Comparison

DCTH vs TTI Comparison

Compare DCTH & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • TTI
  • Stock Information
  • Founded
  • DCTH 1988
  • TTI 1981
  • Country
  • DCTH United States
  • TTI United States
  • Employees
  • DCTH 76
  • TTI N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • TTI Oil & Gas Production
  • Sector
  • DCTH Health Care
  • TTI Energy
  • Exchange
  • DCTH Nasdaq
  • TTI Nasdaq
  • Market Cap
  • DCTH 426.3M
  • TTI 497.7M
  • IPO Year
  • DCTH N/A
  • TTI 1990
  • Fundamental
  • Price
  • DCTH $11.52
  • TTI $3.57
  • Analyst Decision
  • DCTH Strong Buy
  • TTI Strong Buy
  • Analyst Count
  • DCTH 4
  • TTI 2
  • Target Price
  • DCTH $24.00
  • TTI $5.25
  • AVG Volume (30 Days)
  • DCTH 873.0K
  • TTI 1.9M
  • Earning Date
  • DCTH 08-04-2025
  • TTI 07-29-2025
  • Dividend Yield
  • DCTH N/A
  • TTI N/A
  • EPS Growth
  • DCTH N/A
  • TTI 426.72
  • EPS
  • DCTH N/A
  • TTI 0.84
  • Revenue
  • DCTH $53,850,000.00
  • TTI $605,279,000.00
  • Revenue This Year
  • DCTH $155.42
  • TTI $2.67
  • Revenue Next Year
  • DCTH $37.93
  • TTI $7.55
  • P/E Ratio
  • DCTH N/A
  • TTI $4.08
  • Revenue Growth
  • DCTH 1068.87
  • TTI N/A
  • 52 Week Low
  • DCTH $7.17
  • TTI $2.03
  • 52 Week High
  • DCTH $18.23
  • TTI $5.12
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • TTI 57.41
  • Support Level
  • DCTH $12.11
  • TTI $3.19
  • Resistance Level
  • DCTH $14.15
  • TTI $3.65
  • Average True Range (ATR)
  • DCTH 0.57
  • TTI 0.20
  • MACD
  • DCTH -0.16
  • TTI -0.01
  • Stochastic Oscillator
  • DCTH 9.67
  • TTI 67.86

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.

Share on Social Networks: